Global Plasma Fractionation Market Size study & Forecast, by Product ( Albumin, Immunoglobulins, Coagulation Factors, Protease Inhibitors, Others), by Method (Centrifugation, Depth Filtration, Chromatography, Others)by Application (Neurology, Hematology,

Global Plasma Fractionation Market Size study & Forecast, by Product ( Albumin, Immunoglobulins, Coagulation Factors, Protease Inhibitors, Others), by Method (Centrifugation, Depth Filtration, Chromatography, Others)by Application (Neurology, Hematology, Oncology, Immunology, Pulmonology, Others), by End User(Hospitals & Clinics, Clinical Research, Others) and Regional Analysis, 2023-2030


Global Plasma Fractionation Market is valued approximately USD 30.87 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.3% over the forecast period 2023-2030. Plasma fractionation is a process used to separate different components of blood plasma, such as proteins and other bioactive substances. Blood plasma is the liquid component of blood that remains after red blood cells, white blood cells, and platelets have been removed. Plasma fractionation plays a vital role in the production of various therapeutic products, including immunoglobulins, albumin, clotting factors, and other specialized plasma-derived products. These products are used for treating a wide range of medical conditions, such as immune deficiencies, hemophilia, clotting disorders, and certain neurological diseases. The Plasma Fractionation market is expanding because of factors such as growing incidences of immunodeficiency disorders, surge in demand for plasma derived medicinal products and growing geriatric population.

Worldwide, there has been a significant increase in demand for plasma-derived medicines. Strong growth in immunoglobulin demand resulted in positive market expansion on a global scale. The increase in incidence of various immunodeficiency illnesses around the world is the cause of the rising demand. Immunoglobulin substitution therapy or specialized immunoglobulin therapies can be used to treat such illnesses. As a result, the market is driven by the rising demand for these therapies and the consequent growth in immunoglobulin synthesis by these techniques according to UNAIDS, 37.7 million people globally faced Human Immunodeficiency Virus (HIV) in 2020. Along with these, according to The Centres for Disease Control and Prevention (CDC) in the United States in 2021, there were between 3,000 and 6,000 people have the Guillain-Barré Syndrome. The U.S. Food and Drug Administration (FDA) has approved IVIG for use in children with HIV in order to reduce the risk of bacterial infections. The demand for plasma-derived therapies increased as a result of the increasing frequency of various immunodeficiency disorders and other diseases, which aided in the expansion of the global market. In addition, adoption of Plasma Proteins in immunology & neurology procedures and increasing R&D projects involving plasma treatments. The successful launch of this product may provide patients with an alternative option is creating lucrative growth to the market. However, the high cost of plasma fractionation and emergence of recombinant therapies as an alternative to plasma derived medicines stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Plasma Fractionation Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of branded products and the region's increasing disease prevalence. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market player included in this report are:
Grifols S.A.
CSL Limited
Takeda Pharmaceutical Company Limited
Octapharma AG
Kedrion S.p.A
LFB S.A.
Biotest AG
Sanquin
Bio Products Laboratory Ltd.
Intas Pharmaceuticals Ltd

Recent Developments in the Market:
In January 2022, Octapharma AG released information regarding the subcutaneous human immunoglobulin cutaquig, its indication has recently been expanded by the European Union (EU). The expansion would provide patients with acquired immune deficiencies with more diverse treatment options.

In June 2021, LFB Plasma has acquired ImmunoTek Bio Centre. A reliable and continuous supply of plasma will be available in the United States due to the acquisition of the plasma collection facility.

Global Plasma Fractionation Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product, Method, Application, End User, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product:
Albumin
Immunoglobulins
Coagulation Factors
Protease Inhibitors
Others

By Method:
Centrifugation
Depth Filtration
Chromatography
Others

By Application:
Neurology
Hematology
Oncology
Immunology
Pulmonology
Others

By End User:
Hospitals & Clinics
Clinical Research
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned
Grifols S.A.
CSL Limited
Takeda Pharmaceutical Company Limited
Octapharma AG
Kedrion S.p.A
LFB S.A.
Biotest AG
Sanquin
Bio Products Laboratory Ltd.
Intas Pharmaceuticals Ltd

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.


Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Plasma Fractionation Market, by Region, 2020-2030 (USD Billion)
1.2.2. Plasma Fractionation Market, by Product, 2020-2030 (USD Billion)
1.2.3. Plasma Fractionation Market, by Method, 2020-2030 (USD Billion)
1.2.4. Plasma Fractionation Market, by Application, 2020-2030 (USD Billion)
1.2.5. Plasma Fractionation Market, by End User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Plasma Fractionation Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Plasma Fractionation Market Dynamics
3.1. Plasma Fractionation Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Growing Incidences of Immunodeficiency Disorders
3.1.1.2. Surge in Demand for Plasma Derived Medicinal Products
3.1.1.3. Growing Geriatric Population
3.1.2. Market Challenges
3.1.2.1. Emergence of Recombinant Therapies as an Alternative to Plasma Derived Medicines
3.1.3. Market Opportunities
3.1.3.1. Adoption of Plasma Proteins in Immunology & Neurology Procedures
3.1.3.2. Increasing R&D projects involving plasma treatments
Chapter 4. Global Plasma Fractionation Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Plasma Fractionation Market, by Product
5.1. Market Snapshot
5.2. Global Plasma Fractionation Market by Product, Performance - Potential Analysis
5.3. Global Plasma Fractionation Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Plasma Fractionation Market, Sub Segment Analysis
5.4.1. Albumin
5.4.2. Immunoglobulins
5.4.3. Coagulation Factors
5.4.4. Protease Inhibitors
5.4.5. Others
Chapter 6. Global Plasma Fractionation Market, by Method
6.1. Market Snapshot
6.2. Global Plasma Fractionation Market by Method, Performance - Potential Analysis
6.3. Global Plasma Fractionation Market Estimates & Forecasts by Method 2020-2030 (USD Billion)
6.4. Plasma Fractionation Market, Sub Segment Analysis
6.4.1. Centrifugation
6.4.2. Depth Filtration
6.4.3. Chromatography
6.4.4. Others
Chapter 7. Global Plasma Fractionation Market, by Application
7.1. Market Snapshot
7.2. Global Plasma Fractionation Market by Application, Performance - Potential Analysis
7.3. Global Plasma Fractionation Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
7.4. Plasma Fractionation Market, Sub Segment Analysis
7.4.1. Neurology
7.4.2. Hematology
7.4.3. Oncology
7.4.4. Immunology
7.4.5. Pulmonology
7.4.6. Others
Chapter 8. Global Plasma Fractionation Market, by End User
8.1. Market Snapshot
8.2. Global Plasma Fractionation Market by End User, Performance - Potential Analysis
8.3. Global Plasma Fractionation Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
8.4. Plasma Fractionation Market, Sub Segment Analysis
8.4.1. Hospitals & Clinics
8.4.2. Clinical Research
8.4.3. Others
Chapter 9. Global Plasma Fractionation Market, Regional Analysis
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Plasma Fractionation Market, Regional Market Snapshot
9.4. North America Plasma Fractionation Market
9.4.1. U.S. Plasma Fractionation Market
9.4.1.1. Product breakdown estimates & forecasts, 2020-2030
9.4.1.2. Method breakdown estimates & forecasts, 2020-2030
9.4.1.3. Application breakdown estimates & forecasts, 2020-2030
9.4.1.4. End User breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Plasma Fractionation Market
9.5. Europe Plasma Fractionation Market Snapshot
9.5.1. U.K. Plasma Fractionation Market
9.5.2. Germany Plasma Fractionation Market
9.5.3. France Plasma Fractionation Market
9.5.4. Spain Plasma Fractionation Market
9.5.5. Italy Plasma Fractionation Market
9.5.6. Rest of Europe Plasma Fractionation Market
9.6. Asia-Pacific Plasma Fractionation Market Snapshot
9.6.1. China Plasma Fractionation Market
9.6.2. India Plasma Fractionation Market
9.6.3. Japan Plasma Fractionation Market
9.6.4. Australia Plasma Fractionation Market
9.6.5. South Korea Plasma Fractionation Market
9.6.6. Rest of Asia Pacific Plasma Fractionation Market
9.7. Latin America Plasma Fractionation Market Snapshot
9.7.1. Brazil Plasma Fractionation Market
9.7.2. Mexico Plasma Fractionation Market
9.8. Middle East & Africa Plasma Fractionation Market
9.8.1. Saudi Arabia Plasma Fractionation Market
9.8.2. South Africa Plasma Fractionation Market
9.8.3. Rest of Middle East & Africa Plasma Fractionation Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Grifols S.A.
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. CSL Limited
10.3.3. Takeda Pharmaceutical Company Limited
10.3.4. Octapharma AG
10.3.5. Kedrion S.p.A
10.3.6. LFB S.A.
10.3.7. Biotest AG
10.3.8. Sanquin
10.3.9. Bio Products Laboratory Ltd.
10.3.10. Intas Pharmaceuticals Ltd
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
List of Tables
TABLE 1. Global Plasma Fractionation Market, report scope
TABLE 2. Global Plasma Fractionation Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Plasma Fractionation Market estimates & forecasts by Product 2020-2030 (USD Billion)
TABLE 4. Global Plasma Fractionation Market estimates & forecasts by Method 2020-2030 (USD Billion)
TABLE 5. Global Plasma Fractionation Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 6. Global Plasma Fractionation Market estimates & forecasts by End User 2020-2030 (USD Billion)
TABLE 7. Global Plasma Fractionation Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Plasma Fractionation Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Plasma Fractionation Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Plasma Fractionation Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Plasma Fractionation Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Plasma Fractionation Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Plasma Fractionation Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Plasma Fractionation Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Plasma Fractionation Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. Global Plasma Fractionation Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Plasma Fractionation Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 18. U.S. Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. U.S. Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Plasma Fractionation Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 21. Canada Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. Canada Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Plasma Fractionation Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 24. UK Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. UK Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Plasma Fractionation Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 27. Germany Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. Germany Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Plasma Fractionation Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 30. France Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. France Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Plasma Fractionation Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 33. Italy Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Italy Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Plasma Fractionation Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 36. Spain Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. Spain Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Plasma Fractionation Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 39. RoE Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. RoE Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Plasma Fractionation Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 42. China Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. China Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Plasma Fractionation Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 45. India Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. India Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Plasma Fractionation Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 48. Japan Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. Japan Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Plasma Fractionation Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 51. South Korea Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. South Korea Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Plasma Fractionation Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 54. Australia Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. Australia Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Plasma Fractionation Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 57. RoAPAC Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. RoAPAC Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Plasma Fractionation Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 60. Brazil Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Brazil Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Plasma Fractionation Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 63. Mexico Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. Mexico Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Plasma Fractionation Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 66. RoLA Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. RoLA Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. Saudi Arabia Plasma Fractionation Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 69. South Africa Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. RoMEA Plasma Fractionation Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Plasma Fractionation Market
TABLE 72. List of primary sources, used in the study of global Plasma Fractionation Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
FIGURES 1. Global Plasma Fractionation Market, research methodology
FIGURES 2. Global Plasma Fractionation Market, Market estimation techniques
FIGURES 3. Global Market size estimates & forecast methods
FIGURES 4. Global Plasma Fractionation Market, key trends 2022
FIGURES 5. Global Plasma Fractionation Market, growth prospects 2023-2030
FIGURES 6. Global Plasma Fractionation Market, porters 5 force model
FIGURES 7. Global Plasma Fractionation Market, pest analysis
FIGURES 8. Global Plasma Fractionation Market, value chain analysis
FIGURES 9. Global Plasma Fractionation Market by segment, 2020 & 2030 (USD Billion)
FIGURES 10. Global Plasma Fractionation Market by segment, 2020 & 2030 (USD Billion)
FIGURES 11. Global Plasma Fractionation Market by segment, 2020 & 2030 (USD Billion)
FIGURES 12. Global Plasma Fractionation Market by segment, 2020 & 2030 (USD Billion)
FIGURES 13. Global Plasma Fractionation Market by segment, 2020 & 2030 (USD Billion)
FIGURES 14. Global Plasma Fractionation Market, regional snapshot 2020 & 2030
FIGURES 15. North America Plasma Fractionation Market 2020 & 2030 (USD Billion)
FIGURES 16. Europe Plasma Fractionation Market 2020 & 2030 (USD Billion)
FIGURES 17. Asia pacific Plasma Fractionation Market 2020 & 2030 (USD Billion)
FIGURES 18. Latin America Plasma Fractionation Market 2020 & 2030 (USD Billion)
FIGURES 19. Middle East & Africa Plasma Fractionation Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings